1. McLure HA, Rubin AP. Review of local anaesthetic agents. Minerva Anestesiol. 2005; 71:59–74.
2. Malamed SF. Handbook of Local Anesthesia. Sixth edition. 2014.
3. Ping B, Kiattavorncharoen S, Saengsirinavin C, Im P, Durward CS. Effect of high concentration lidocaine for mandibular teeth anesthesia: Review of literature. M Dent J. 2014; 34:364–372.
4. Brand HS, Abraham-Inpijn L. Cardiovascular responses induced by dental treatment. Eur J Oral Sci. 1996; 104:245–252.
5. Sapira JD, Bron K. Human epinephrine secretion. Direct measurement of the secretion of epinephrine from the human adrenal medulla. J Clin Endocrinol Metab. 1971; 33:436–447.
6. Lipp M, Dick W, Daublander M, Fuder H, Stanton-Hicks M. Exogenous and endogenous plasma levels of epinephrine during dental treatment under local anesthesia. Reg Anesth. 1993; 18:6–12.
7. Troullos ES, Goldstein DS, Hargreaves KM, Dionne RA. Plasma epinephrine levels and cardiovascular response to high administered doses of epinephrine contained in local anesthesia. Anesth Prog. 1987; 34:10–13.
8. Becker DE, Reed KL. Local anesthetics: review of pharmacological considerations. Anesth Prog. 2012; 59:90–101.
9. de Morais HH, de Santana Santos T, Araujo FA, Vajgel A, de Holanda Vasconcellos RJ. Hemodynamic changes comparing lidocaine HCl with epinephrine and articaine HCl with epinephrine. J Craniofac Surg. 2012; 23:1703–1708.
10. Malamed SF. Pain and anxiety in dentistry. Sedation: a guide to patient management. 4th ed. St Louis: Mosby;2003. p. 2–6.
11. Ezmek B, Arslan A, Delilbasi C, Sencift K. Comparison of hemodynamic effects of lidocaine, prilocaine and mepivacaine solutions without vasoconstrictor in hypertensive patients. J Appl Oral Sci. 2010; 18:354.
12. Yagiela JA. Local anesthetics. Anesth Prog. 1991; 38:128–141.
13. Grant DA, Lie T, Clark SM, Adams DF. Pain and discomfort levels in patients during root surface debridement with sonic metal or plastic inserts. J Periodontol. 1993; 64:645–650.
14. Dionne RA, Goldstein DS, Wirdzek PR. Effects of diazepam premedication and epinephrine-containing local anesthetic on cardiovascular and plasma catecholamine responses to oral surgery. Anesth Analg. 1984; 63:640–646.
15. Santos CF, Modena KC, Giglio FP, et al. Epinephrine concentration (1:100,000 or 1:200,000) does not affect the clinical efficacy of 4% articaine for lower third molar removal: a double-blind, randomized, crossover study. J Oral Maxillofac Surg. 2007; 65:2445–2452.
16. Moore PA, Boynes SG, Hersh EV, et al. The anesthetic efficacy of 4 percent articaine 1:200,000 epinephrine: two controlled clinical trials. J Am Dent Assoc. 2006; 137:1572–1581.
17. Malamed SF, Gagnon S, Leblanc D. Articaine hydrochloride: a study of the safety of a new amide local anesthetic. J Am Dent Assoc. 2001; 132:177–185.
18. Vreeland DL, Reader A, Beck M, Meyers W, Weaver J. An evaluation of volumes and concentrations of lidocaine in human inferior alveolar nerve block. J Endod. 1989; 15:6–12.
19. Rood JP. Inferior alveolar nerve blocks. The use of 5 per cent lignocaine. Br Dent J. 1976; 140:413–414.
20. Rood JP, Cannell H. Plasma levels of lignocaine after peri-oral injections of two different concentrations. Pharmacol Ther Dent. 1978; 3:45–47.
21. Sandy J, Rood JP. Five per cent lignocaine solution in children\'s dentistry. J Dent. 1980; 8:312–314.
22. Eldridge DJ, Rood JP. A double-blind trial of 5 per cent lignocaine solution. Br Dent J. 1977; 142:129–130.
23. Lima JL Jr, Dias-Ribeiro E, Ferreira-Rocha J, et al. Comparison of buccal infiltration of 4% articaine with 1 : 100,000 and 1 : 200,000 epinephrine for extraction of maxillary third molars with pericoronitis: a pilot study. Anesth Prog. 2013; 60:42–45.
24. Hiller A, Karjalainen K, Balk M, Rosenberg PH. Transient neurological symptoms after spinal anaesthesia with hyperbaric 5% lidocaine or general anaesthesia. Br J Anaesth. 1999; 82:575–579.
25. Kanai Y, Katsuki H, Takasaki M. Lidocaine disrupts axonal membrane of rat sciatic nerve in vitro. Anesth Analg. 2000; 91:944–948.